Letters to the Editor

A recent L.A. Times article “exposes the folly of President Trump’s cancellation of U.S. government research projects, the result being that other countries are already offering jobs to those researchers who have lost their funding,” writes a reader.

“We’ve waited far too long for progress,” writes an L.A. Times reader. “It took decades for today’s experimental drugs to reach human testing, and many never make it to approval.”

“The president’s bizarre claims that NPR fails to provide ‘fair, accurate or unbiased’ programming can be summarily rejected by those who actually listen to the variety of viewpoints included,” writes an L.A. Times reader.

Businesses that are standing up to President Trump ‘should inspire resistance to the current administration’s crusade to dismantle our democratic institutions,’ writes an L.A. Times reader.

‘His message, laced with hostility toward judges, immigrants and political opponents, was not a remembrance of sacrifice but a desecration of it,’ writes an L.A. Times reader.